ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 129 filers reported holding ALLAKOS INC in Q1 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,522 | -32.2% | 8,600 | +30.3% | 0.00% | -50.0% |
| Q2 2023 | $28,776 | +74.8% | 6,600 | +78.4% | 0.00% | +100.0% |
| Q1 2023 | $16,465 | -92.5% | 3,700 | -89.7% | 0.00% | -94.1% |
| Q3 2022 | $219,000 | +338.0% | 35,924 | +124.5% | 0.02% | +240.0% |
| Q2 2022 | $50,000 | -47.9% | 15,999 | -5.9% | 0.01% | -37.5% |
| Q1 2022 | $96,000 | +128.6% | 17,002 | +4087.7% | 0.01% | +166.7% |
| Q3 2021 | $42,000 | -89.3% | 406 | -91.2% | 0.00% | -90.3% |
| Q2 2021 | $392,000 | +931.6% | 4,594 | +1267.3% | 0.03% | +675.0% |
| Q1 2021 | $38,000 | -17.4% | 336 | +1.8% | 0.00% | -20.0% |
| Q4 2020 | $46,000 | +21.1% | 330 | -63.3% | 0.01% | +25.0% |
| Q2 2019 | $38,000 | – | 900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 270,965 | $12,055,000 | 6.94% |
| NEA Management Company, LLC | 2,268,188 | $100,912,000 | 5.27% |
| Fairmount Funds Management LLC | 178,662 | $7,949,000 | 4.82% |
| Redmile Group, LLC | 2,976,928 | $132,444,000 | 3.71% |
| Boxer Capital, LLC | 675,000 | $30,031,000 | 2.05% |
| Rock Springs Capital Management LP | 235,000 | $10,455,000 | 0.43% |
| Cormorant Asset Management, LP | 200,000 | $8,898,000 | 0.41% |
| RAMIUS ADVISORS LLC | 31,155 | $1,386,000 | 0.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 15,700 | $692,000 | 0.32% |
| Handelsinvest Investeringsforvaltning | 20,000 | $890,000 | 0.24% |